Jenoptik Supervisory Board extends Executive Board contracts for Dr. Ralf Kuschnereit and Dr. Prisca Havranek-Kosicek by five years

At its regular meeting on March 24, 2025, the Supervisory Board of JENOPTIK AG unanimously decided to extend the contracts of Dr. Ralf Kuschnereit, responsible for the former Advanced Photonic Solutions division, and Chief Financial Officer Dr. Prisca Havranek-Kosicek ahead of schedule by five years each until December 31, 2030, and February 28, 2031, respectively.

“Jenoptik has been very successful in developing into a focused photonics group in recent years. The continuous further development of the company by the proven Executive Board team under the leadership of Dr. Traeger creates the basis for realizing the growth potential and thus consistently implementing our strategy,” says Matthias Wierlacher, Chairman of the Supervisory Board of JENOPTIK AG.

Within the Executive Board, Dr. Ralf Kuschnereit has been responsible for the “Semiconductor & Advanced Manufacturing” and “Biophotonics” Strategic Business Units created in connection with the Jenoptik Group’s new reporting structure since January 1, 2025. His responsibilities also include the North America region as well as the areas of Business System & Operational Excellence, Corporate Innovation & Digital Transformation, Purchasing, Quality, Environment, Health & Safety (EHS) and Intellectual Property. Dr. Ralf Kuschnereit has been a member of the Executive Board of JENOPTIK AG since January 2023.

Dr. Prisca Havranek-Kosicek has been a member of the Jenoptik Executive Board since March 2023 and took over the role of Chief Financial Officer in April 2023. Since January 1, 2025, she has been responsible for Corporate Real Estate and Internal Audit in addition to Finance, Tax, Insurance, Treasury, Sustainability, Investor Relations and IT.

Dr. Stefan Traeger, President & CEO of JENOPTIK AG, said: “I look forward to continuing to work with my colleagues on the Executive Board. Together we will continue to develop Jenoptik in the interests of our employees, customers and shareholders.”

Management images are available for download in the Jenoptik image database.

This press release may contain statements relating to the future which are based on current assumptions and forecasts made by the corporate management of the Jenoptik Group. A variety of known and unknown risks, uncertainties, and other factors may cause the actual results, the financial situation, the development, or the performance of the company to diverge significantly from the information provided here. Such factors may include geopolitical conflicts, changes in currency exchange rates and interest rates, pandemics, the introduction of competing products, or a change in business strategy. The company does not assume any obligation to update such forward-looking statements in the light of future developments.

About Jenoptik

Jenoptik is a global technology group operating in the photonics market. Our growth areas primarily include semiconductor technology, medical technology, metrology as well as smart mobility. Approximately 4,600 people worldwide work for the Jenoptik Group, which is headquartered in Jena (Germany). JENOPTIK AG is listed on the German Stock Exchange in Frankfurt and traded on the MDax and TecDax. In fiscal year 2024, Jenoptik generated revenue of around 1.12 billion euros.